According to FutureWise analysis the market for biosimilar growth hormones is expected to register a CAGR of 8.62% from 2025-2033. A biosimilar, often referred to as a follow-on biologic or subsequent entry biologic, represents a significant advancement in the pharmaceutical industry. Think of it as a cousin to an original biological product, crafted by a different company once the patent on...